Robert Luo

At Minnesota Medical Technologies, our mission is to develop, manufacture, and deliver continence care products of unmatched performance, comfort, and quality worldwide. With more than 30 years of experience in silicone technology, our team has invented, developed, and launched successful continence care products that have improved the lives of millions globally. Today, we’re introducing the next breakthrough: StaySure™, the first-of-its-kind, clinically backed solution for accidental bowel leakage (ABL). Our innovative silicone insert offers immediate, comfortable protection for up to 24 hours, empowering individuals to stay active, social, and in control of their lives.

Arthrosi Therapeutics is a leading clinical-stage biotech company dedicated to advancing therapies for gout disease. Our proprietary oral drug candidate, AR882 which is currently in clinical Phase 3, has demonstrated unprecedented sustained urate lowering in gout patients and reduction of tophi, showing exceptional potential to treat millions of patients suffering from gout and tophaceous gout. At Arthrosi Therapeutics, we are committed to transforming the treatment landscape and improving the lives of patients worldwide.

Verve Medical, Inc. is an early-stage medical device company committed to developing novel, trans- urethral, natural orifice, Renal Denervation devices to ameliorate treatment-resistant hypertension and associated diseases for the benefit of patients world-wide.

Melodi Health offers novel technologies that improve patient outcomes for women undergoing breast surgery. Melodi Health manufactures the Melodi Matrix, designed to support the soft tissue space around a prosthetic device while delivering antibiotics to the surrounding tissue. The Melodi Matrix is currently an investigational device being studied in a prospective, multi-center, randomized, controlled clinical trial in breast reconstruction.

Zepto Life Technology (St. Paul, Minnesota, United States) is an innovator in molecular diagnostics, committed to delivering the industrys most accurate, rapid, multiplexed, and user-friendly solutions for diagnosing life-threatening infections. They are developing a highly multiplexed panel of pathogens using Nobel prize-winning Giant Magnetoresistance (GMR) technology to bypass traditional culture methods. In addition to creating this innovative tool, Zepto operates diagnostic labs and offers Contract Research Organization (CRO) services to help other companies bring their diagnostic tests to market.

Based in Rockville, Maryland, OncoC4 is a privately held, late clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel biologics for the potential treatment of cancer. Its lead clinical candidate is BNT316/ONC-392, a next generation anti-CTLA-4 antibody that is designed to allow CTLA-4 to recycle and maintain its protective function against autoimmune diseases while enhancing anti-tumor activity at the same time. In addition, OncoC4 has a pipeline of potentially first-in-class preclinical product candidates focusing on the CD24-Siglecs cancer immune evasion pathway.

Airiver Medical is a clinical stage company developing technologies to help patients who suffer from certain respiratory tract conditions. The company aims to improve the current standard of care for central airway stenosis and chronic rhinosinusitis (CRS).

Osteal Therapeutics is a privately held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.

GIE Medical is a clinical stage company conducting trials in the US helping patients who suffer from benign stricture(s) of the esophagus and bowel (small intestine, colon, and rectum). GIE Medical’s Drug Coated Balloon could offer a new solution for treating GI strictures. Potentially creating sustained patency and reducing the number of treatments.

At Minnesota Medical Technologies, our mission is to develop, manufacture, and deliver continence care products of unmatched performance, comfort, and quality worldwide. With more than 30 years of experience in silicone technology, our team has invented, developed, and launched successful continence care products that have improved the lives of millions globally. Today, we’re introducing the next breakthrough: StaySure™, the first-of-its-kind, clinically backed solution for accidental bowel leakage (ABL). Our innovative silicone insert offers immediate, comfortable protection for up to 24 hours, empowering individuals to stay active, social, and in control of their lives.

Arthrosi Therapeutics is a leading clinical-stage biotech company dedicated to advancing therapies for gout disease. Our proprietary oral drug candidate, AR882 which is currently in clinical Phase 3, has demonstrated unprecedented sustained urate lowering in gout patients and reduction of tophi, showing exceptional potential to treat millions of patients suffering from gout and tophaceous gout. At Arthrosi Therapeutics, we are committed to transforming the treatment landscape and improving the lives of patients worldwide.

Verve Medical, Inc. is an early-stage medical device company committed to developing novel, trans- urethral, natural orifice, Renal Denervation devices to ameliorate treatment-resistant hypertension and associated diseases for the benefit of patients world-wide.

Melodi Health offers novel technologies that improve patient outcomes for women undergoing breast surgery. Melodi Health manufactures the Melodi Matrix, designed to support the soft tissue space around a prosthetic device while delivering antibiotics to the surrounding tissue. The Melodi Matrix is currently an investigational device being studied in a prospective, multi-center, randomized, controlled clinical trial in breast reconstruction.

Zepto Life Technology (St. Paul, Minnesota, United States) is an innovator in molecular diagnostics, committed to delivering the industrys most accurate, rapid, multiplexed, and user-friendly solutions for diagnosing life-threatening infections. They are developing a highly multiplexed panel of pathogens using Nobel prize-winning Giant Magnetoresistance (GMR) technology to bypass traditional culture methods. In addition to creating this innovative tool, Zepto operates diagnostic labs and offers Contract Research Organization (CRO) services to help other companies bring their diagnostic tests to market.